Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
Global Genetic Testing Market Size Forecast to 2023 - ResearchAndMarkets.com
12:00am, Wednesday, 26'th Aug 2020
The
Charting a bullish technical tilt, S&P 500 breaks to record territory
04:46pm, Tuesday, 25'th Aug 2020
Technically speaking, the U.S. benchmarks’ already-bullish bigger-picture backdrop continues to strengthen, writes Michael Ashbaugh.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
10X Genomics Inc (NASDAQ: TXG)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Avenue Therapeutics Inc (NASDAQ: ATXI)...
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
Charting a pulling-teeth breakout attempt: S&P 500, Nasdaq challenge record territory
04:41pm, Tuesday, 18'th Aug 2020
Technically speaking, the S&P 500 and Nasdaq Composite have registered nominal record highs this week, though a pulling-teeth breakout attempt remains...
Joint Guideline from ACOG and SMFM Supports use of Non-Invasive Prenatal Testing (NIPT) for all Pregnant Women
01:03pm, Tuesday, 18'th Aug 2020
Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive prenatal testing, announced a joint guideline released yesterday by the American College of Obstetrics and Gynecology (ACOG) and Society of Matern
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Return On Capital Employed Overview: Natera
04:09pm, Thursday, 13'th Aug 2020
During Q2, Natera's (NASDAQ: NTRA) reported sales totaled $86.47 million. Despite a 48.14% in earnings, the company posted a loss of $51.66 million. In Q1, Natera brought in $94.01 million in sales bu
Charting the approach of record highs, S&P 500 rises amid market rotation
04:49pm, Tuesday, 11'th Aug 2020
Technically speaking, the U.S. benchmarks’ already-bullish backdrop has strengthened amid rotational August price action, writes Michael Ashbaugh.
The Natera (NASDAQ:NTRA) Share Price Has Soared 366%, Delighting Many Shareholders
03:17pm, Tuesday, 11'th Aug 2020
For us, stock picking is in large part the hunt for the truly magnificent stocks. You won't get it right every time...
Shareholders Are Raving About How The Natera (NASDAQ:NTRA) Share Price Increased 366%
03:16pm, Tuesday, 11'th Aug 2020
We think that it's fair to say that the possibility of finding fantastic multi-year winners is what motivates many...
Natera Files Additional Suit Against ArcherDX
01:03pm, Friday, 07'th Aug 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed suit yesterday against ArcherDX, Inc. for infringement of Natera's U.S. Patent No. 10,731,220 (the "'220 Patent
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
12:00am, Friday, 07'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 6)
ADiTx Therapeutics Inc (NASDAQ: ADTX) (announced introduction of AditxtScore for COVID-19 to be used in detecting...
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
10:35pm, Wednesday, 05'th Aug 2020
Natera (NTRA) delivered earnings and revenue surprises of -21.05% and 17.77%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Natera Reports Second Quarter 2020 Financial Results
08:05pm, Wednesday, 05'th Aug 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the second quarter ended June 30, 2020 and provided an update on recent business
